SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate Change

10 Sep 2020 14:45

RNS Number : 6593Y
TP ICAP PLC
10 September 2020
Β 

TP ICAP plc

Β 

Appointment of Non-executive Director

Β 

TP ICAP plc (the "Company") is pleased to announce that Kath Cates is to be appointed a Non-executive Director of the Company and will become a member of the Company's Risk, Audit and Nominations & Governance Committees. She will assume the positions with effect from 1 February 2021. Following the 2021 AGM in May next year, Ms Cates will assume the role of Chair of the Risk Committee following Michael Heaney's term as Interim Chair. Mr Heaney will remain on the Company's Board and a member of the Risk, Remuneration and Nominations & Governance Committees.

Β 

A qualified lawyer, Ms Cates has spent over 25 years in global financial services both in the UK and overseas. She was previously Global Chief Operations Officer, Wholesale Banking for Standard Chartered plc, responsible for a broad portfolio including risk, technology, operations, legal and compliance, HR, strategy and marketing. Prior to that she spent 22 years at UBS in roles spanning legal, operations, risk and compliance.

Β 

Since 2013 Ms Cates has focused on her non-executive roles, gaining considerable experience on the boards of a number of companies, as a member and chair of main board committees, and undertaking the role of senior independent director.

Β 

Ms Cates is currently a non-executive director of RSA Insurance Group plc, chairing the remuneration committee and also a member of the risk, audit and nominations committees, and a non-executive director, chair of the risk committee and member of the audit and nominations committees of Brewin Dolphin Holdings plc. She is also a non-executive director of Threadneedle Investment Services Limited, Threadneedle Pensions Limited and Threadneedle Asset Management Holdings Sarl. Most recently Ms Cates was appointed a non-executive director of United Utilities Group plc where she is a member of the remuneration and nomination committees and is a non-executive director of United Utilities Water Limited.

Β 

Commenting on Ms Cates' appointment, Richard Berliand, Chairman of TP ICAP plc, said:

Β 

"We are delighted to welcome Kath to the Board of the Company. She brings extensive broad-based experience from a career working in a regulated environment in financial services both in the UK and abroad. This, combined with significant experience from her non-executive directorship roles, will enable her to make a strong contribution to our Board."

Β 

TP ICAP plc confirms that there are no other details that are required to be disclosed under 9.6.13R of the Listing Rules of the Financial Conduct Authority.

Β 

Β 

ENDS

Β 

Richard Cordeschi

Group Company Secretary

Richard.Cordeschi@tpicap.comΒ 

+44 (0) 20 7200 7331

Β 

For media enquiries please contact:

Β 

William Baldwin-Charles,

Group Media Relations Director

William.Baldwin-Charles@tpicap.com

+44 (0) 20 7200 7124

Β 

For investor enquiries please contact:

Β 

Al AlevizakosHead of Investor Relations and FP&AAlevizos.Alevizakos@tpicap.com

+44 (0) 20 3933 3040

Β 

Β 

About TP ICAP

Β 

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data &; analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAEADNEFDKEEFA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:25 pmRNSDirector/PDMR Shareholding
22nd May 202612:45 pmRNSHolding(s) in Company
13th May 20264:12 pmRNSResult of AGM
13th May 20264:12 pmRNSDirectorate change
13th May 20267:00 amRNSTrading Statement
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20269:00 amRNS2025 Annual Report and Notice of 2026 AGM
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20269:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:05 amRNSLaunch of sixth share buyback programme of £80m
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
5th Nov 20257:00 amRNSTrading Statement
2nd Oct 202510:15 amRNSDirector Declaration
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:30 amRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:30 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:50 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.